SHARP (2011) — Trial Summary
SHARP (2011): Combination of simvastatin plus ezetimibe reduced major atherosclerotic events in patients with CKD.
References
- Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181-2192.